MINK THERAPEUTICS INC (INKT) Stock Analyst Ratings
USA - NASDAQ:INKT - US6036932019 - Common Stock
12.98 USD
-0.24 (-1.82%)
ChartMill assigns a Buy % Consensus number of 83% to INKT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.78. This target is 206.47% above the current price.
INKT was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about INKT.
In the previous month the buy percentage consensus was at a similar level.
INKT was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-15 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-07-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-07-14 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-22 | Evercore ISI Group | Maintains | Outperform |
| 2023-03-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-10 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-11-09 | William Blair | Initiate | Outperform |
| 2021-11-09 | Evercore ISI Group | Initiate | Outperform |
| 2021-11-09 | Baird | Initiate | Outperform |
MINK THERAPEUTICS INC / INKT FAQ
What do analysts expect the price target to be for MINK THERAPEUTICS INC (INKT)?
8 analysts have analysed INKT and the average price target is 39.78 USD. This implies a price increase of 206.47% is expected in the next year compared to the current price of 12.98.
Can you provide the consensus rating for MINK THERAPEUTICS INC stock?
The consensus rating for MINK THERAPEUTICS INC (INKT) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed MINK THERAPEUTICS INC (INKT)?
The number of analysts covering MINK THERAPEUTICS INC (INKT) is 8.